Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 91301-91350 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05127226
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
PHASE1/PHASE2
Recruiting
70 participants
Started: Dec 22, 2021 · Completed: Mar 31, 2029
1 condition
1 sponsor
11 locations
NCT05188092
Lung Ultrasound-Guided Fluid Deresuscitation in ICU Patients
NA
Recruiting
1,000 participants
Started: Dec 22, 2021 · Completed: Dec 1, 2025
4 conditions
2 sponsors
3 locations
NCT06420843
Microbiota, Metabolome and Nutrition: an 'Artificially Intelligent' Way to Personalized Nutrition
NA
Recruiting
48 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05191381
Immune Modulation by Exosomes in COVID-19
N/A
Recruiting
40 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT05166850
Preventative Intervention for Cholera for 7 Days
NA
Recruiting
2,900 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2025
3 conditions
3 sponsors
2 locations
NCT05051891
A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma
PHASE3
Recruiting
356 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
22 locations
NCT05145907
Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors
PHASE2
Active, not recruiting
133 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2024
2 conditions
1 sponsor
20 locations
NCT05117619
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
NA
Recruiting
440 participants
Started: Dec 22, 2021 · Completed: May 30, 2026
1 condition
5 sponsors
1 location
NCT06856993
Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death
N/A
Recruiting
300 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05184816
A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
PHASE1
Recruiting
35 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2025
1 condition
3 sponsors
7 locations
NCT05269394
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
PHASE2/PHASE3
Active, not recruiting
197 participants
Started: Dec 22, 2021 · Completed: Jul 31, 2028
3 conditions
5 sponsors
38 locations
NCT05113069
A Study of SHR-A1912 for Injection in Patients With B Cell Lymphomas
PHASE1
Enrolling by invitation
170 participants
Started: Dec 22, 2021 · Completed: Mar 30, 2025
1 condition
1 sponsor
1 location
NCT05054439
A Clinical Study of SI-B001 in Combination With Paclitaxel in the Treatment of Recurrent and Metastatic HNSCC
PHASE2
Active, not recruiting
42 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
7 locations
NCT06571955
ACL Reconstruction with a New Generation of LARS Artificial Ligament
NA
Active, not recruiting
40 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04685590
Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study
PHASE2
Active, not recruiting
48 participants
Started: Dec 22, 2021 · Completed: Jan 31, 2029
2 conditions
3 sponsors
5 locations
NCT05890456
Students With Involved Families and Teachers
NA
Recruiting
320 participants
Started: Dec 22, 2021 · Completed: Jun 30, 2026
3 conditions
1 sponsor
1 location
NCT04965519
A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies
PHASE2
Recruiting
120 participants
Started: Dec 21, 2021 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05153772
Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients
PHASE2
Active, not recruiting
69 participants
Started: Dec 21, 2021 · Completed: Oct 31, 2028
1 condition
2 sponsors
4 locations
NCT05209620
Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma
PHASE2
Recruiting
30 participants
Started: Dec 21, 2021 · Completed: Dec 21, 2026
1 condition
1 sponsor
1 location
NCT04947384
Pulmonary Vascular Hemodynamics Before and After Mitral Valve Procedures
N/A
Recruiting
120 participants
Started: Dec 21, 2021 · Completed: Jan 20, 2026
1 condition
1 sponsor
1 location
NCT05228470
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
PHASE2
Active, not recruiting
39 participants
Started: Dec 21, 2021 · Completed: Oct 31, 2025
11 conditions
1 sponsor
15 locations
NCT04958811
Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC
PHASE2
Active, not recruiting
29 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT04997811
Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes
PHASE2
Recruiting
120 participants
Started: Dec 21, 2021 · Completed: Jun 30, 2025
1 condition
6 sponsors
19 locations
NCT05165979
Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil
N/A
Active, not recruiting
650 participants
Started: Dec 21, 2021 · Completed: Jul 1, 2024
4 conditions
1 sponsor
24 locations
NCT05098613
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
PHASE1
Recruiting
20 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05068388
Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density
PHASE2
Active, not recruiting
240 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05800925
Triage Survey for Psychiatry Research Eligibility
N/A
Recruiting
2,000 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2025
3 conditions
1 sponsor
3 locations
NCT06323278
Effectiveness of Cognitive Stimulation Treatment in Patients With Parkinson's Disease
N/A
Recruiting
68 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05553886
S086 Tablets for Chronic Heart Failure With Reduced Ejection Fraction
PHASE3
Recruiting
5 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05031078
Assessing Durable Antibody Response to HPV Vaccination
PHASE4
Active, not recruiting
17 participants
Started: Dec 21, 2021 · Completed: May 31, 2026
1 condition
1 sponsor
2 locations
NCT05068544
Adolescent Normative Sport Movement Analysis
N/A
Recruiting
40 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05130827
Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)
PHASE2
Active, not recruiting
17 participants
Started: Dec 21, 2021 · Completed: Nov 30, 2025
1 condition
2 sponsors
7 locations
NCT05115474
Study of Screening Brain MRIs in Stage IV Breast Cancer
N/A
Recruiting
170 participants
Started: Dec 21, 2021 · Completed: Oct 31, 2026
3 conditions
2 sponsors
2 locations
NCT05141201
SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)
N/A
Active, not recruiting
1,620 participants
Started: Dec 21, 2021 · Completed: Nov 30, 2025
1 condition
1 sponsor
47 locations
NCT05979675
Acute Myeloid Leukemia Registry
N/A
Recruiting
250 participants
Started: Dec 21, 2021 · Completed: Dec 21, 2026
1 condition
1 sponsor
1 location
NCT06124599
Prodromes of Menstrual Staphylococcal Toxic Shock
N/A
Recruiting
316 participants
Started: Dec 21, 2021 · Completed: Dec 21, 2026
1 condition
1 sponsor
1 location
NCT05621343
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
N/A
Recruiting
130 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2024
3 conditions
1 sponsor
1 location
NCT05521503
Biopsy Collection and Repository Database
N/A
Recruiting
400 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT04905069
Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy
NA
Active, not recruiting
500 participants
Started: Dec 21, 2021 · Completed: Apr 30, 2030
1 condition
1 sponsor
30 locations
NCT04919226
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
PHASE3
Active, not recruiting
259 participants
Started: Dec 21, 2021 · Completed: Sep 30, 2027
1 condition
1 sponsor
42 locations
NCT05074420
A Study of Baricitinib (LY3009104) in Children With COVID-19
PHASE3
Recruiting
24 participants
Started: Dec 21, 2021 · Completed: May 31, 2026
2 conditions
1 sponsor
14 locations
NCT05154799
Developmental Coordination Disorder
NA
Recruiting
280 participants
Started: Dec 21, 2021 · Completed: Jan 21, 2027
2 conditions
1 sponsor
1 location
NCT05145062
Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.
N/A
Enrolling by invitation
12 participants
Started: Dec 21, 2021 · Completed: Jul 14, 2038
1 condition
1 sponsor
7 locations
NCT05197036
A Global Clinical Study Investigating the Safety and Effectiveness of Smith and Nephew's Porous Knee System in Patients Who Need a Total Knee Replacement Due to Degenerative Arthritis, Post-traumatic Arthritis or Inflammatory Arthritis
N/A
Active, not recruiting
299 participants
Started: Dec 21, 2021 · Completed: Dec 25, 2028
3 conditions
1 sponsor
21 locations
NCT04572880
Evaluation of Minimal Invasive Glaucoma Surgery
NA
Recruiting
150 participants
Started: Dec 21, 2021 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05155137
Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)
PHASE3
Recruiting
8,518 participants
Started: Dec 20, 2021 · Completed: Dec 14, 2030
2 conditions
3 sponsors
2 locations
NCT05159193
Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer
PHASE3
Recruiting
372 participants
Started: Dec 20, 2021 · Completed: Jan 31, 2028
1 condition
2 sponsors
1 location
NCT04533750
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
PHASE1
Active, not recruiting
42 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
18 conditions
2 sponsors
27 locations
NCT04769206
Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans
PHASE1/PHASE2
Recruiting
88 participants
Started: Dec 20, 2021 · Completed: Feb 1, 2027
1 condition
1 sponsor
1 location
NCT05464849
Evaluation of Systemic Microvascular Reactivity in Patients With Resistant Hypertension
N/A
Recruiting
150 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
Previous
1
More pages
1824
1825
1826
1827
1828
1829
1830
More pages
2369
Next